Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas.
Cicin İ, Özatlı T, Türkmen E, Özturk T, Özçelik M, Çabuk D, Gökdurnalı A, Balvan Ö, Yıldız Y, Şeker M, Özdemir N, Yapar B, Tanrıverdi Ö, Günaydin Y, Menekşe S, Öksüzoğlu B, Aksoy A, Erdogan B, Bekir Hacıoglu M, Arpaci E, Sevinç A. Cicin İ, et al. Among authors: ozatli t. Balkan Med J. 2016 Sep;33(5):517-524. doi: 10.5152/balkanmedj.2016.151268. Epub 2016 Sep 1. Balkan Med J. 2016. PMID: 27761279 Free PMC article.
Clinicopathologic characteristics, treatment outcomes, and prognostic factors of primary thoracic soft tissue sarcoma: A multicenter study of the Anatolian Society of Medical Oncology (ASMO).
Unal OU, Oztop I, Yasar N, Urakci Z, Ozatli T, Bozkurt O, Sevinc A, Gunaydin Y, Yapar Taskoylu B, Arpaci E, Ulas A, Kodaz H, Tonyali O, Avci N, Aksoy A, Yilmaz AU. Unal OU, et al. Among authors: ozatli t. Thorac Cancer. 2015 Jan;6(1):85-90. doi: 10.1111/1759-7714.12150. Epub 2015 Jan 7. Thorac Cancer. 2015. PMID: 26273340 Free PMC article.
Comparison the efficacy of second-line modified EOX (epirubicin, oxaliplatin, and capecitabine) and irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) regimens in metastatic gastric cancer patients that progressed on first-line modified docetaxel and cisplatin plus fluorouracil (DCF) regimen.
Sendur MA, Ozdemir N, Özatlı T, Yazıcı O, Aksoy S, Ekinci AS, Yazılıtaş D, Günaydın Y, Oksuzoglu B, Benekli M, Zengin N. Sendur MA, et al. Among authors: ozatli t. Med Oncol. 2014 Sep;31(9):153. doi: 10.1007/s12032-014-0153-y. Epub 2014 Aug 7. Med Oncol. 2014. PMID: 25099765
Treatment and prognostic factors in primary peritoneal carcinoma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO).
Unal OU, Oztop I, Yazici O, Ozatli T, Inal A, Günaydın Y, Alici S, Demirci U, Cinkir HY, Aktas B, Aslan K, Uncu D, Yilmaz AU, Oksuzoglu B, Buyukberber S. Unal OU, et al. Among authors: ozatli t. Oncol Res Treat. 2014;37(6):332-8. doi: 10.1159/000362857. Epub 2014 May 19. Oncol Res Treat. 2014. PMID: 24903764 Clinical Trial.
Gastric carcinoma with bone marrow metastasis: a case series.
Ekinci AŞ, Bal O, Ozatlı T, Türker I, Eşbah O, Demirci A, Budakoğlu B, Arslan UY, Eraslan E, Oksüzoğlu B. Ekinci AŞ, et al. Among authors: ozatli t. J Gastric Cancer. 2014 Mar;14(1):54-7. doi: 10.5230/jgc.2014.14.1.54. Epub 2014 Mar 31. J Gastric Cancer. 2014. PMID: 24765538 Free PMC article.
Comprehensive tumor molecular profile analysis in clinical practice.
Özdoğan M, Papadopoulou E, Tsoulos N, Tsantikidi A, Mariatou VM, Tsaousis G, Kapeni E, Bourkoula E, Fotiou D, Kapetsis G, Boukovinas I, Touroutoglou N, Fassas A, Adamidis A, Kosmidis P, Trafalis D, Galani E, Lypas G, Orhan B, Tansan S, Özatlı T, Kırca O, Çakır O, Nasioulas G. Özdoğan M, et al. Among authors: ozatli t. BMC Med Genomics. 2021 Apr 14;14(1):105. doi: 10.1186/s12920-021-00952-9. BMC Med Genomics. 2021. PMID: 33853586 Free PMC article.
Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing.
Agiannitopoulos K, Pepe G, Tsaousis GN, Potska K, Bouzarelou D, Katseli A, Ntogka C, Meintani A, Tsoulos N, Giassas S, Venizelos V, Markopoulos C, Iosifidou R, Karageorgopoulou S, Christodoulou C, Natsiopoulos I, Papazisis K, Vasilaki-Antonatou M, Kabletsas E, Psyrri A, Ziogas D, Lalla E, Koumarianou A, Anastasakou K, Papadimitriou C, Ozmen V, Tansan S, Kaban K, Ozatli T, Eniu DT, Chiorean A, Blidaru A, Rinsma M, Papadopoulou E, Nasioulas G. Agiannitopoulos K, et al. Among authors: ozatli t. Cancer Genomics Proteomics. 2023 Sep-Oct;20(5):448-455. doi: 10.21873/cgp.20396. Cancer Genomics Proteomics. 2023. PMID: 37643779 Free PMC article.
11 results